Valion Bio appoints Dean Zikria interim CEO effective Sep 22, 2026
Valion Bio, Inc. signed a consulting agreement with Dean Zikria as Interim Chief Executive Officer, effective September 22, 2026. The deal includes monthly fees, RSUs, and cash bonuses tied to strategic transactions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed